Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Denise Zou"'
Publikováno v:
Breast, Vol 60, Iss , Pp 302- (2021)
Externí odkaz:
https://doaj.org/article/bf369c07d6ae47069e433ad534d3652a
Autor:
Margaret Hux, Denise Zou, Esprit Ma, Peter Sajosi, Andreas Engstrom, Ross Selby, Eugene Benson, Andrew Briggs, Vijayveer Bonthapally
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 4, Iss 2 (2016)
**Objective:** To evaluate the cost-effectiveness of brentuximab vedotin in patients with R/R sALCL from a UK NHS perspective. **Methods:** A partitioned survival model used clinical outcomes for brentuximab vedotin from the pivotal phase-2 single-a
Externí odkaz:
https://doaj.org/article/7d27a3d6afc843208c70026aeb5511d8
Autor:
Denise Zou, Weicheng Ye, Lisa M. Hess, Naleen Raj Bhandari, Amine Ale-Ali, Jacinda Foster, Peter Quon, Mack Harris
Publikováno v:
The Journal of molecular diagnostics : JMD. 24(8)
The study evaluated the diagnostic value and cost-effectiveness of next-generation sequencing (NGS)-based testing versus various combinations of single-gene tests (SGTs) for selection of first-line treatment for patients with advanced/metastatic non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::790c092d34b1c75b73f38ca88870b273
https://pubmed.ncbi.nlm.nih.gov/35688357
https://pubmed.ncbi.nlm.nih.gov/35688357
Autor:
Michal Litkiewicz, Sandra Milev, Linda Tirapelle, Hannah K. Gaggin, Serge Masson, Uwe Siebert, Denise Zou, James L. Januzzi
Publikováno v:
The American journal of cardiology. 147
Our objective was to perform an economic evaluation of an N-terminal pro B-type natriuretic peptide (NT-proBNP)-supported diagnostic strategy in dyspneic patients suspected of acute heart failure in the emergency department (ED). A decision-tree mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b822d82f180a2c1422dedff4856c078
https://pubmed.ncbi.nlm.nih.gov/33617809
https://pubmed.ncbi.nlm.nih.gov/33617809
Autor:
Naomi M. Simon, Lauren M. Laifer, Mark H. Pollack, Bonnie Y. Ohye, Philip Held, Denise Zou, Eric Bui, Niranjan S. Karnik, Julia C. Sager, Alyson K. Zalta, Paula K. Rauch
Publikováno v:
Zalta, AK; Bui, E; Karnik, NS; Held, P; Laifer, LM; Sager, JC; et al.(2018). Examining the Relationship Between Parent and Child Psychopathology in Treatment-Seeking Veterans. CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 49(2), 209-216. doi: 10.1007/s10578-017-0743-y. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/3x81k0sw
Child Psychiatry and Human Development
Child Psychiatry and Human Development
This study aimed to examine: (1) the relationship between parental psychopathology and child psychopathology in military families and (2) parenting sense of competence as a mediator of the relationship between veteran psychopathology and child psycho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a9af0fcbca5672d412a48c11611c016
https://doi.org/10.1007/s10578-017-0743-y
https://doi.org/10.1007/s10578-017-0743-y
Publikováno v:
Blood. 134:5852-5852
I ntroduction Acute myeloid leukemia (AML) is an orphan disease and has one of the lowest five-year survival rates among myeloid malignancies in United States (US) adults (28.3% on average, 5% of which are aged 65 years or older). Older patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccc2de5b962c720652653ad514bd665d
https://doi.org/10.1182/blood-2019-122709
https://doi.org/10.1182/blood-2019-122709
Autor:
Tatyana Feldman, Wenkang Ma, Mayvis Rebeira, Mack Harris, Denise Zou, Joseph K. T. Lee, Joseph Feliciano, Shangbang Rao, Michelle A. Fanale, Thomas Manley, Anuraag Kansal
Publikováno v:
Journal of Clinical Oncology. 37:e19060-e19060
e19060 Background: The most common frontline treatment for peripheral T-cell lymphoma (PTCL) is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or a CHOP-like regimen. In the recently reported phase 3 ECHELON-2 trial, brentuximab ve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be3338f6a96509e4c587135489e72ea6
https://doi.org/10.1200/jco.2019.37.15_suppl.e19060
https://doi.org/10.1200/jco.2019.37.15_suppl.e19060
Budget Impact of First-Line Bosutinib for Chronic Phase Chronic Myeloid Leukemia on a US Health Plan
Publikováno v:
Blood. 132:5834-5834
Introduction: Tyrosine kinase inhibitors (TKIs) have transformed the treatment paradigm for chronic myeloid leukemia (CML). Although not curative, TKIs have increased the life expectancy of patients with CML to approximately that of the general popul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbc935395b13704f5e4a87c2e2bfebd3
https://doi.org/10.1182/blood-2018-99-110544
https://doi.org/10.1182/blood-2018-99-110544
Autor:
Douglas J. Demetrick, Konrad Fassbender, Robert C. Lee, Denise Zou, Douglas A. Stewart, Lisa M. DiFrancesco
Publikováno v:
Value in Health. 11(2):221-230
Objective The objective of this study was to provide a detailed comparative microcosting analysis for two cancer treatment pathways to contribute evidence for resource allocation and operational decision-making in a Canadian cancer care context. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7000ad5fce2e5958c4693e37e6bacbcd
Autor:
Esprit Ma, Margaret Hux, Vijayveer Bonthapally, Jeremy Teasell, Ross Selby, Denise Zou, Akshara Richhariya, Peter Sajosi, Andreas Engstrom, Andrew Briggs, Eugene Benson
Publikováno v:
Journal of Clinical Oncology. 34:18-18
18 Background: Systemic anaplastic large cell lymphoma (sALCL) is a rare T-cell lymphoma. For patients who fail front-line therapy, outcomes are poor and there is no current defined standard of care. Brentuximab vedotin has demonstrated high objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a04ec4c7fde2e79c3ca5ce774b0f320a
https://doi.org/10.1200/jco.2016.34.7_suppl.18
https://doi.org/10.1200/jco.2016.34.7_suppl.18